Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2006, Vol. 4 ›› Issue (5): 490-494.doi: 10.3736/jcim20060510

• Original Experimental Research • Previous Articles     Next Articles

Effects of Runing Recipe medicated serum on expressions of genes in breast cancer cells

Sheng Liu1,Xiao-hong Xue1,Xin-wei Yang1,De-ming Lu2   

  1. 1. Department of Chinese Traditional Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    2. Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Online:2006-09-30 Published:2006-09-15


To explore the mechanisms of the effects of Runing Recipe in anti-invasion and anti-recurrence of breast cancer by experimental research in vitro.


SD female rats were randomly divided into Runing Recipe-treated group and its decomposed formulas Kidney-Warming Recipe and Liver-Soothing Recipe-treated groups, tamoxifen (TAM) -treated group, cyclophosphamide (CTX) -treated group, and normal control group to make medicated serums. Methods of matrigel basement membrane and real-time reverse transcription polymerase chain reaction were employed to investigate the gene expressions of vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) after MDA-MB-435 cells were treated with the medicated serums.


The gene expression of VEGF was dropped in CTX-treated, TAM-treated and Liver-Smoothing Recipe-treated groups. The gene expression of TIMP-1 was up-regulated in CTX-treated, Runing Recipe-treated and Kidney-Warming Recipe-treated groups; while MMP-9 was down-regulated in these groups.


The mechanisms of Runing Recipe in inhibiting the cancer cell invasion may be related to down-regulating the gene expressions of VEGF and MMP-9, and up-regulating the gene expression of TIMP-1.

Key words: Runing Recipe, Breast cancer, Experiment in vitro, RT-PCR

CLC Number: 

  • R285.5

Table 1

Effects of different drug-containing-serums on invasive ability of MDA-MB-435 cells in vitro (ヌ±S )"

Group n Cells number Inhibition rate (%)
Normal control 4 105.25±10.05
Runing Recipe-treated 4 67.00±9.97** 36.3
Kidney-Warming Recipe-treated 4 86.00±4.69* 18.3
Liver-Soothing Recipe-treated 4 101.25±12.71 3.8
Tamoxifen-treated 4 95.50±9.40 9.3
Cyclophosphamide-treated 4 72.25±11.09** 31.4

Table 2

Values of cycle threshold of VEGF、MMP-9 and TIMP-1 expression in 6 groups"

Normal control 19.95 25.66 29.26
Runing Recipe-treated 21.25 29.09 25.36
Kidney-Warming Recipe-treated 20.37 32.73 24.56
Liver-Soothing Recipe-treated 23.50 25.63 28.70
Tamoxifen-treated 23.08 26.10 28.82
Cyclophosphamide-treated 23.43 31.83 23.93
[1] 薛晓红, 刘胜, 杨新伟 , 等. 乳宁冲剂及其拆方对裸鼠移植瘤肺转移的抑制作用与机制探讨[J]. 天津中医药, 2005,22(4):320-323
doi: 10.3969/j.issn.1672-1519.2005.04.024
[2] 薛晓红, 刘胜, 杨新伟 , 等. 乳宁冲剂及拆方对裸鼠移植瘤生长及肺转移的影响[J]. 上海中医药杂志, 2005,39(7):45-47
doi: 10.3969/j.issn.1007-1334.2005.07.022
[3] 陈奇 . 中药药理实验(第1版)[M]. 贵阳: 贵州人民出版社, 1998,( 第1版):230
[4] 李仪奎 . 中药血清药理学实验方法的若干问题[J]. 中药新药与临床药理, 1999,10(2):95-98
doi: 10.3321/j.issn:1003-9783.1999.02.011
[5] Shao ZM, Wu J, Shen ZZ , et al. Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines[J]. Anticancer Res, 1998,18(3A):1435-1439
[6] Ferrara N, Davis-Smyth T . The biology of vascular endothelial growth factor[J]. Endocr Rev, 1997,18(1):4-25
doi: 10.1007/978-1-4613-0389-3_7
[7] Senger DR , Van de Water L, Bromn LF , et al.Vascular permeability factor(VPF, VEGF) in tumor biology[J]. Cancer Metastasis Rev, 1993,12(3-4):303-324
doi: 10.1007/BF00665960 pmid: 8281615
[8] Minchenko A, Bauer T, Sulceda S , et al. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and vivo[J]. Lab Invest, 1994,71(3):374-379
doi: 10.1084/jem.180.3.1177 pmid: 7933988
[9] Levy AP, Levy NS, Goldberg MA . Post-transcriptional regulation of vascular endothelial growth factor by hypoxia[J]. J Biol Chem, 1996,271(5):2746-2753
[10] Liotta LA, Steeg PS, Stetler-Steveson WG . Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation[J]. Cell, 1991,64(2):327-336
doi: 10.1016/0092-8674(91)90642-C pmid: 1703045
[11] Siegal GP, Barsky SH, Terranova VP , et al. Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrance components. An immunoperoxidase study[J]. Invasion Metastasis, 1981,1(1):54-70
[12] Sreenath T, Matrisian LM, Stetler-Stevenson W , et al. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential[J]. Cancer Res, 1992,52(18):4942-4947
[13] Rha SY, Kim JH, Roh JK , et al. Sequential production and activation of matrix-metalloproteinase-9(MMP-9) with breast cancer progression[J]. Breast Cancer Res Treat, 1997,43(2):175-181
[14] Yoshimoto M, Itoh F, Yamamoto H , et al. Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers[J]. Int J Cancer, 1993,54(4):614-725
doi: 10.1002/ijc.2910540415 pmid: 8514452
[15] 黄晓曦, 许东坡, 陈依期 , 等. TIMP-1在乳腺癌中的表达及其抗浸润机制的研究[J]. 中国肿瘤, 2002,11(1):59-61
doi: 10.3969/j.issn.1004-0242.2002.01.050
[16] Imren S, Kohn DB, Shimada H , et al. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion[J]. Cancer Res, 1996,56(13):2891-2895
[17] Declerck YA, Perez N, Shimada H , et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases[J]. Cancer Res, 1992,52(3):701-708
[18] Kawamata H, Kawai K, Kameyama S , et al. Over-expression of tissue inhibitor of matrix metalloproteinases(TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma[J]. Int J Cancer, 1995,63(5):680-687
[19] Lindsay CK, Thorgeirsson UP, Tsuda H , et al. Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer[J]. Hum Pathol, 1997,28(3):359-366
[1] Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
[2] Fatemeh Sadat Hasheminas, Seyed Mehdi Hashemi, Azizallah Dehghan, Fariba Sharififar, Mohammad Setayesh, Pegah Sasanpour, Mojtaba Tasbandi, Mahboobeh Raeiszadeh. Effects of a Plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial. Journal of Integrative Medicine, 2020, 18(3): 214-221.
[3] Carlos R. Oliveira, Daniel G. Spindola, Daniel M. Garcia, Adolfo Erustes, Alexandre Bechara, Caroline Palmeira-dos-Santos, Soraya S. Smaili, Gustavo J.S. Pereira, André Hinsberger, Ezequiel P. Viriato, Maria Cristina Marcucci, Alexandra C.H.F. Sawaya, Samantha L. Tomaz, Elaine G. Rodrigues, Claudia Bincoletto. Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development. Journal of Integrative Medicine, 2019, 17(2): 132-140.
[4] Lizhou Liu, Simone Petrich, Blair McLaren, Lyndell Kelly, G. David Baxter. An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy: Study protocol for a randomized controlled feasibility study. Journal of Integrative Medicine, 2018, 16(2): 99-105.
[5] Gloria Gronowicz, Eric R. Secor Jr., John R. Flynn, Liisa T. Kuhn. Human biofield therapy does not affect tumor size but modulates immune responses in a mouse model for breast cancer. Journal of Integrative Medicine, 2016, 14(5): 389-399.
[6] Mei-qun Cao, Zheng-zhi Wu, Wei-kang Wu. Identification of salivary biomarkers in breast cancer patients with thick white or thick yellow tongue fur using isobaric tags for relative and absolute quantitative proteomics. Journal of Chinese Integrative Medicine, 2011, 9(3): 275-280.
[7] Mei-na Ye, Hong-feng Chen, Rui-juan Zhou, Ming-juan Liao. Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line. Journal of Chinese Integrative Medicine, 2011, 9(12): 1339-1346.
[8] Ying Deng , Hong-feng Chen. Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines. Journal of Chinese Integrative Medicine, 2009, 7(12): 1174-1180.
[9] Mei-na Ye, Hong-feng Chen. Effects of Astragalus injection on proliferation of basal-like breast cancer cell line MDA-MB-468. Journal of Chinese Integrative Medicine, 2008, 6(4): 399-403.
[10] Sheng Liu, Jing Zhao, Jia Liu, Zhen-ping Sun, Yong-qiang Hua, De-ming Lu, Han-jun Tang. Effects of Ru'ai Shuhou Recipe on 5-year recurrence rate after mastectomy in breast cancer. Journal of Chinese Integrative Medicine, 2008, 6(10): 1000-1004.
[11] Sheng-fang Hu, Hong-feng Chen, Qian-wen Rong. Assessing breast cancer risk in women with mammary hyperplasia of different syndromes using mammography. Journal of Chinese Integrative Medicine, 2007, 5(2): 195-.
[12] Sheng Liu, Yong-qiang Hua, Zhen-ping Sun, Song Tan, De-ming Lu. Clinical observation of Ruyiping in preventing recidivation and metastasis of breast cancer. Journal of Chinese Integrative Medicine, 2007, 5(2): 147-149.
[13] Sheng Liu, Yong-qiang Hua, Zhen-ping Sun, Song Tan, De-ming Lu. Breast cancer pathogenesis of stagnation of phlegm, poison and blood stasis: rationale and clinical application in traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2007, 5(2): 122-125.
[14] TANG Xin. Experience of Professor Han-jun Tang in treating breast cancer after operation based on syndrome differentiation. Journal of Chinese Integrative Medicine, 2007, 5(2): 201-203.
[15] Xiu-fei Gao, Sheng Liu. Influencing factors and psychotherapies of psychogenic problems in breast cancer patients. Journal of Chinese Integrative Medicine, 2007, 5(2): 213-215.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228